Cargando…

The analysis of the effect of the COVID-19 pandemic on patients with hereditary angioedema type I and type II

Due to the similarity between the pathomechanism of SARS-CoV-2 infections and hereditary angioedema due to C1-inhibitor deficiency (C1-INH-HAE), a possibility emerged that C1-INH-HAE may worsen the course of the infection, or that the infection may influence the severity of angioedema (HAE) attacks...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szilágyi, Dávid, Horváth, Hanga Réka, Andrási, Noémi, Kempler, Miklós Soma, Balla, Zsuzsanna, Farkas, Henriette
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665366/ https://www.ncbi.nlm.nih.gov/pubmed/37993569 http://dx.doi.org/10.1038/s41598-023-47307-1

Ejemplares similares

Hypersensitivity reactions amongst Hungarian Patients with Hereditary Angioedema due to C1-Inhibitor Deficiency
por: Horváth, Hanga Réka, et al.
Publicado: (2023)

Diagnosing Pediatric Patients With Hereditary C1-Inhibitor Deficiency—Experience From the Hungarian Angioedema Center of Reference and Excellence
por: Andrási, Noémi, et al.
Publicado: (2022)

Overview of SERPING1 Variations Identified in Hungarian Patients With Hereditary Angioedema
por: Szabó, Edina, et al.
Publicado: (2022)

The characteristics of upper airway edema in hereditary and acquired angioedema with C1‐inhibitor deficiency
por: Balla, Zsuzsanna, et al.
Publicado: (2021)

Application of a dried blood spot based proteomic and genetic assay for diagnosing hereditary angioedema
por: Iuraşcu, Marius‐Ionuţ, et al.
Publicado: (2023)

458 Differences of Complement Activation Profile between Type I and Type II of Hereditary Angioedema Due to C1-inhibitor Deficiency
por: Csuka, Dorottya, et al.
Publicado: (2012)

Decreased adhesion to endothelium leads to elevated neutrophil granulocyte count in hereditary angioedema patients
por: Kajdácsi, Erika, et al.
Publicado: (2023)

The Global Registry for Hereditary Angioedema due to C1-Inhibitor Deficiency
por: Zanichelli, Andrea, et al.
Publicado: (2021)

Patient‐physician interactions in hereditary angioedema—Key learnings from the coronavirus disease 2019 pandemic
por: Maurer, Marcus, et al.
Publicado: (2023)

Blood Clotting and the Pathogenesis of Types I and II Hereditary Angioedema
por: de Maat, Steven, et al.
Publicado: (2021)

Anti-cholesterol antibody levels in hereditary angioedema
por: Varga, Lilian, et al.
Publicado: (2007)

455 Characterization of the Factors Triggering an Edematous Attack in Hereditary Angioedema
por: Zotter, Zsuzsanna, et al.
Publicado: (2012)

Frequency of the virilising effects of attenuated androgens reported by women with hereditary angioedema
por: Zotter, Zsuzsanna, et al.
Publicado: (2014)

Management of upper airway edema caused by hereditary angioedema
por: Farkas, Henriette
Publicado: (2010)

Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey
por: Longhurst, H. J., et al.
Publicado: (2017)

Pediatric hereditary angioedema due to C1-inhibitor deficiency
por: Farkas, Henriette
Publicado: (2010)

The influence of trigger factors on hereditary angioedema due to C1-inhibitor deficiency
por: Zotter, Zsuzsanna, et al.
Publicado: (2014)

Screening for Plasminogen Mutations in Hereditary Angioedema Patients
por: Farkas, Henriette, et al.
Publicado: (2021)

The effect of long-term danazol treatment on haematological parameters in hereditary angioedema
por: Kőhalmi, Kinga Viktória, et al.
Publicado: (2016)

Glucocorticoid receptor gene polymorphisms in hereditary angioedema with C1-inhibitor deficiency
por: Zotter, Zsuzsanna, et al.
Publicado: (2017)

Home treatment with conestat alfa in attacks of hereditary angioedema due to C1-inhibitor deficiency
por: Farkas, Henriette, et al.
Publicado: (2015)

Neutrophils Are Dysregulated in Patients with Hereditary Angioedema Types I and II in a Symptom-Free Period
por: Grymova, Tereza, et al.
Publicado: (2019)

Neutrophil activation during attacks in patients with hereditary angioedema due to C1-inhibitor deficiency
por: Veszeli, Nóra, et al.
Publicado: (2015)

Long term follow-up of complement parameters to improve the management of acquired angioedema due to C1-inhibitor deficiency
por: Polai, Zsofia, et al.
Publicado: (2022)

How Angioedema Quality of Life Questionnaire Can Help Physicians in Treating C1-Inhibitor Deficiency Patients?
por: Balla, Zsuzsanna, et al.
Publicado: (2021)

163 The Efficacy of Human Plasma-Derived C1-Inhibitor Concentrate Used for Prophylactic Treatment in Patients With Hereditary Angioedema Due to C1-Inhibitor Deficiency
por: Csuka, Dorottya, et al.
Publicado: (2012)

Comparison of the Frequency of Angioedema Attack, before and during Pregnancy, in a Patient with Type I Hereditary Angioedema
por: Satomura, Atsushi, et al.
Publicado: (2017)

Perioperative management of emergency caesarean section in type I hereditary angioedema
por: Srinivasan, Gnanasekaran, et al.
Publicado: (2022)

Ecallantide is a novel treatment for attacks of hereditary angioedema due to C1 inhibitor deficiency
por: Farkas, Henriette, et al.
Publicado: (2011)

Type-III hereditary angioedema resolved by surgery
por: Fu, Lisa W, et al.
Publicado: (2014)

Hereditary Angioedema Type 1 with Recurrent Dizziness
por: Ando, Takashi, et al.
Publicado: (2019)

WAO Guideline for the Management of Hereditary Angioedema
por: Craig, Timothy, et al.
Publicado: (2012)

National survey on clinical and genetic characteristics of patients with hereditary angioedema in Latvia
por: Kanepa, Adine, et al.
Publicado: (2023)

Canadian hereditary angioedema guideline
por: Betschel, Stephen, et al.
Publicado: (2014)

Oral Surgery Procedures in a Patient Affected by Hereditary Angioedema Type I
por: Cinquini, Chiara, et al.
Publicado: (2022)

Comprehensive study into the activation of the plasma enzyme systems during attacks of hereditary angioedema due to C1-inhibitor deficiency
por: Csuka, Dorottya, et al.
Publicado: (2015)

An evidence-based review of the potential role of icatibant in the treatment of acute attacks in hereditary angioedema type I and II
por: Floccard, Bernard, et al.
Publicado: (2012)

Therapeutic trial in hereditary angioedema type III: Icatibant
por: Garro, Laila Sabino, et al.
Publicado: (2015)

C1-inhibitor/C1-inhibitor antibody complexes in acquired angioedema due to C1-inhibitor deficiency
por: Polai, Zsofia, et al.
Publicado: (2023)

Influence of COVID-19 pandemic and vaccination on the menstrual cycle: A retrospective study in Hungary
por: Barabás, Klaudia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fdsr04j3q783bcrg940ts40lr4